Shukra Pharmaceuticals Limited (BOM:524632)

Shukra Pharmaceuticals Income Statement

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Operating Revenue	348	325.87	745.73	588.34	204.86	111.96
Other Revenue	45.99	42.07	18.93	6.59	-0	-
Revenue	393.99	367.94	764.66	594.93	204.86	111.96
Revenue Growth (YoY)	-34.87%	-51.88%	28.53%	190.41%	82.97%	-5.49%
Cost of Revenue	88.65	81.12	445.34	454.25	105.17	27.69
Gross Profit	305.34	286.82	319.31	140.68	99.69	84.27
Selling, General & Admin	65.52	61.1	81.76	53.83	55.4	44.76
Other Operating Expenses	61.4	56.36	20.96	21.88	14.94	21.97
Operating Expenses	158.19	147.51	123.22	94.09	86.96	81.47
Operating Income	147.15	139.32	196.09	46.59	12.73	2.8
Interest Expense	-8.01	-5.95	-2.76	-2.56	-2.81	-0.13
Interest & Investment Income	-	-	5.59	0.64	0.31	0.47
Other Non Operating Income (Expenses)	-0	-0	-0.09	-0.25	-0.05	-0.2
EBT Excluding Unusual Items	139.13	133.37	198.83	44.42	10.18	2.93
Other Unusual Items	-	-	-	-	-	-1.95
Pretax Income	139.13	133.37	198.83	44.42	10.18	0.98
Income Tax Expense	37.94	37.61	13.46	0.35	2.67	-0.9
Net Income	101.19	95.75	185.37	44.07	7.51	1.88
Net Income to Common	101.19	95.75	185.37	44.07	7.51	1.88
Net Income Growth	-45.60%	-48.35%	320.68%	486.98%	299.10%	428.31%
Shares Outstanding (Basic)	553	435	438	67	63	63
Shares Outstanding (Diluted)	553	435	438	67	63	63
Shares Change (YoY)	15.86%	-0.60%	551.03%	7.38%	-	0.02%
EPS (Basic)	0.18	0.22	0.42	0.66	0.12	0.03
EPS (Diluted)	0.18	0.22	0.42	0.66	0.12	0.03
EPS Growth	-53.05%	-48.03%	-35.38%	446.67%	299.10%	428.20%
Free Cash Flow	-	51.75	-69.57	-13.22	64.39	-12.54
Free Cash Flow Per Share	-	0.12	-0.16	-0.20	1.03	-0.20
Dividend Per Share	-	-	0.100	0.013	0.013	-
Dividend Growth	-	-	700.00%	-	-	-
Gross Margin	77.50%	77.95%	41.76%	23.65%	48.66%	75.27%
Operating Margin	37.35%	37.86%	25.64%	7.83%	6.21%	2.50%
Profit Margin	25.68%	26.02%	24.24%	7.41%	3.66%	1.68%
Free Cash Flow Margin	-	14.07%	-9.10%	-2.22%	31.43%	-11.20%
EBITDA	179.58	169.37	216.59	64.96	29.35	17.53
EBITDA Margin	45.58%	46.03%	28.33%	10.92%	14.33%	15.66%
D&A For EBITDA	32.44	30.05	20.5	18.38	16.62	14.74
EBIT	147.15	139.32	196.09	46.59	12.73	2.8
EBIT Margin	37.35%	37.86%	25.64%	7.83%	6.21%	2.50%
Effective Tax Rate	27.27%	28.20%	6.77%	0.79%	26.26%	-
Revenue as Reported	393.99	367.94	773.88	600.3	205.67	115.52
Advertising Expenses	-	-	21.21	0.1	0.09	0.41

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.